Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Abdominal Radiology (New York)
|
May 17, 2018
Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment
Medhat Aker, Darren Boone, Anuradha Chandramohan, et al.
Journal of the National Cancer Institute
|
August 6, 2015
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer
Peter Hoskin, Santhanam Sundar, Krystyna Reczko, et al.
The New England Journal of Medicine
|
April 20, 2012
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
Nicholas D James, Syed A Hussain, Emma Hall, et al.
The Lancet. Oncology
|
April 8, 2014
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Harpreet Wasan, Angela M Meade, Richard Adams, et al.
British Journal of Cancer
|
September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
Simon Gollins, Nick West, David Sebag-Montefiore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2021
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
Shih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
The Lancet. Oncology
|
November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
John C Araujo, Géralyn C Trudel, Fred Saad, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Abdominal Radiology (New York)
|
May 17, 2018
Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment
Medhat Aker, Darren Boone, Anuradha Chandramohan, et al.
Journal of the National Cancer Institute
|
August 6, 2015
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer
Peter Hoskin, Santhanam Sundar, Krystyna Reczko, et al.
The New England Journal of Medicine
|
April 20, 2012
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
Nicholas D James, Syed A Hussain, Emma Hall, et al.
The Lancet. Oncology
|
April 8, 2014
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Harpreet Wasan, Angela M Meade, Richard Adams, et al.
British Journal of Cancer
|
September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
Simon Gollins, Nick West, David Sebag-Montefiore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2021
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
Shih-Hsin Chen, Kenneth Miles, Stuart A Taylor, et al.
The Lancet. Oncology
|
November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
John C Araujo, Géralyn C Trudel, Fred Saad, et al.
Page
of 1